Payment Terms | T/T, D/A, D/P |
Supply Ability | 500000/Day |
Delivery Time | 5-7 work day |
Packaging Details | Carton |
Specimen | Nasal Swab |
Quanlity Guarantee Period | 24 months |
Specificity | 100.00% |
Sensitivity | 98.50% |
Total Accuracy | 99.30% |
Test Time | <15 min |
Material | Test cassette |
Group | All People |
Storage Condition | 2℃-30℃ |
Brand Name | LABNOVATION |
Model Number | LX-401302 |
Certification | ISO13485,ISO9001,CE |
Place of Origin | China |
View Detail Information
Explore similar products
SARS-CoV-2 IVD Reagent Rapid Antigen Self Test Kit Individual Labnovation Test
Single Pack High Specificity Antigen Self Test Kit For SARS-CoV-2
SARS-CoV-2 95% Accuracy Antigen Rapid Testing Kit With Strong C T Line
Nasal Swab CoV 19 Plastic Antigen Self Test Kit OEM ODM
Product Specification
Payment Terms | T/T, D/A, D/P | Supply Ability | 500000/Day |
Delivery Time | 5-7 work day | Packaging Details | Carton |
Specimen | Nasal Swab | Quanlity Guarantee Period | 24 months |
Specificity | 100.00% | Sensitivity | 98.50% |
Total Accuracy | 99.30% | Test Time | <15 min |
Material | Test cassette | Group | All People |
Storage Condition | 2℃-30℃ | Brand Name | LABNOVATION |
Model Number | LX-401302 | Certification | ISO13485,ISO9001,CE |
Place of Origin | China | ||
High Light | Swabs Rapid Antigen Self Test Kit ,99.30 Accuracy Antigen Self Test Kit ,Nasal Swab Rapid Antigen Test Kit |
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
Clinical Use
Accurate rapid diagnostic tests for SARS-CoV-2 infection could contribute to clinical and public health strategies to manage the COVID-19 pandemic. Point-of-care antigen and molecular tests to detect current infection could increase access to testing and early confirmation of cases, and expediate clinical and public health management decisions that may reduce transmission.
Main Components
Test Cassettes
Sample tubes
Extraction Buffer
Swabs
Tube stand
Instruction for use
Package specification
1T/Box,5T/Box
Product Feature
High accuracy, specificity and sensitivity
Detectino of mutations
Safety and Reliability
Simple operation, No extra instrument
Results in 15minutes and easy to read
Intend Use
This rapid test kit is designed to qualitatively detect the SARS-CoV-2 virus nucleocapsid antigen from the nasal secretions of individuals suspected of COVID-19.
Use Step
Result Interpretation
POSITIVE: Two colored bands appear on the membrane. One band appears in the control region (C) and another band appears in the test region (T).
NEGATIVE: Only one colored band appears, in the control region (C). No apparent colored band appears in the test region (T).
INVALID: If there is no Control line (C) or only a Test line (T) in the result window, the test did not run correctly and the results are not valid.
Virus Sources
Global high frequency mutation | Alpha / B.1.1.7(U.K.) | Beta I B.1.351(South Africa) |
Gemma I P.1(Brazil) | Kappa I B.1.617.1(India) | Delta I B.1.617.2(India) |
C.37,ect | Alpha I B.1.17(U.K.) | B.1.36.16.etc |
A.2.5,etc | A.23.1 | Alpha I B.1.17(U.K.) |
B.1.1.33.etc | C.1.1.etc. |
Certificate (CE approved)
Company Details
Business Type:
Manufacturer
Year Established:
2001
Total Annual:
10000000-50000000
Employee Number:
100~600
Ecer Certification:
Active Member
Labnovation Technologies, Inc. is an original manufacturer established in Shenzhen, China since 2001. We are dedicated in developing and manufacturing IVD instruments and reagents including HbA1c analyzer and reagents, rapid test reader & reagents, hematology reagents, clinical chemistry reagent... Labnovation Technologies, Inc. is an original manufacturer established in Shenzhen, China since 2001. We are dedicated in developing and manufacturing IVD instruments and reagents including HbA1c analyzer and reagents, rapid test reader & reagents, hematology reagents, clinical chemistry reagent...
Get in touch with us
Leave a Message, we will call you back quickly!